Gufic Biosciences Ltd — Quarterly Results & Earnings

₹273.80

-4.82%

Profit Growth YoY-31.40%Latest quarter

Sales Growth YoY12.85%Latest quarter

Sales CAGR 5Y16.69%5 year compound

Profit CAGR 5Y25.23%5 year compound

📋

Quarterly Performance

YoY Profit Growth-31.40%

🔴 Significant decline

YoY Sales Growth+12.85%

✅ Strong growth

OPM 5Y Average

Operating profit margin

18.21%

EPS Growth 5Y

19.04%

Interest Coverage

Higher = safer debt servicing

3.30

ROE

12.32%

ROCE

13.18%

💡

Growth Analysis

Gufic Biosciences Ltd reported YoY profit growth of -31.40% and revenue growth of 12.85% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 16.69% and profits at 25.23% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Gufic Biosciences Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.